AINeutralGoogle DeepMind Blog · May 166/10
🧠
Accelerating discovery of liver disease mechanisms
Filippo Menolascina leverages Co-Scientist AI to accelerate the discovery of liver disease mechanisms and identify new treatment options. The research aims to explain why certain existing drugs are effective only for specific patient populations, potentially enabling more personalized therapeutic approaches.
